Home » Portfolio » Neurovalens

Neurovalens

Neurovalens makes non-invasive technology that treats type 2 diabetes by stimulating the area of the brainstem that regulates glucose. Phase III trials are scheduled to finish in late 2022.

Website: https://neurovalens.com

Location: United Kingdom

Crunchbase: https://www.crunchbase.com/organization/neurovalens

Last Update: June 29th, 2022

Neurovalens Logo
Jason McKeown, Founder & CEO, Neurovalens
Neurovalens Logo